A clinical trial associated with leptin has been updated with a status change on October 16, 2026. The study, registered as NCT05920785, is titled "Clinical and Metabolic, Immunological and Microbiological Characteristics of Obese Patients." According to the trial record, the study status is listed as completed. No phase information was provided for this trial in the available record. The update reflects the trial's current status designation only, as recorded on ClinicalTrials.gov. No results, outcomes, or findings were included in this status update. The record does not specify efficacy data, safety data, or conclusions drawn from the study. This brief reflects only the status and title information provided in the trial record as of the stated date. Readers interested in further details about the trial design or eventual results should consult the official trial registration directly. For general background on leptin, including its approved regulatory status, see the compound overview.
Leptin Study NCT05920785 Marked Completed as of Oct 16, 2026
Source: https://clinicaltrials.gov/study/NCT05920785